Search

everythinglearnresearchcommunity

for

Search:↓

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Ozone therapy might improve cancer treatment and reduce its side effects.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Hair loss from cancer treatment is very distressing for women due to its impact on self-image and social stigma.

Hair casts and cutaneous spicules can be signs of multiple myeloma.

Chemotherapy toxicity might be reduced by using DNA neutralizing agents.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

Suppressing eIF4E can prevent hair loss from chemotherapy.

Hair mass index is a precise way to measure hair loss in chemotherapy patients.

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

Scalp cooling helps prevent hair loss and improves quality of life during chemotherapy.

Certain blood markers can help predict and manage chemotherapy side effects in older cancer patients.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Taxane chemotherapy can cause permanent hair loss by damaging hair follicles and altering their DNA.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Eliminating senescent cells can prevent and reverse chemotherapy-induced peripheral neuropathy.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

Horticultural therapy helped cancer patients feel hopeful and positive about their disease experience.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.